ArticleCureus2025
Confronting Cholelithiasis: A Case Series of Patients With Sickle Cell Disease and Gallstones.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is a prevalent hemoglobinopathy that leads to various complications, including hepatobiliary diseases, which are often underrecognized. Cholelithiasis and choledocholithiasis, resulting from accelerated pigment gallstone formation due to increased hemolysis, are common in SCD patients. This case series aims to raise awareness of the heightened risk of biliary disease in SCD and emphasize the need for early screening and management strategies. We present four cases of adult SCD patients who developed gallstones, each requiring medical intervention for biliary complications. The first case involved a 47-year-old woman with SCD and choledocholithiasis, presenting with right upper quadrant pain and jaundice. She underwent a laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP) for stone removal. The second case described a 25-year-old woman with a history of SCD, who had hyperbilirubinemia and dilated common hepatic duct. She successfully underwent ERCP and laparoscopic cholecystectomy after cholelithiasis was confirmed. The third case involved a 34-year-old man with acute abdominal pain and right-sided testicular pain, diagnosed with gallstones and early cholecystitis. Despite plans for surgery, he signed out against medical advice. The fourth case was a 28-year-old woman with recurrent acute chest syndrome, who presented with abdominal pain and was found to have multiple gallstones. She underwent laparoscopic cholecystectomy, but developed acute chest syndrome postoperatively, requiring exchange transfusion. All patients experienced post-surgical recovery, although one patient had complications related to acute chest syndrome. Hepatobiliary manifestations in SCD include cholelithiasis, choledocholithiasis, and other liver-related issues. The formation of pigmented gallstones is a direct result of chronic hemolysis, where increased bilirubin levels contribute to stone formation. The incidence of cholelithiasis in SCD patients is significant, with factors such as hemoglobin levels and bilirubin elevation increasing the likelihood of gallstone formation. Symptomatic gallstones often present with right upper quadrant pain, which can be exacerbated by vaso-occlusive crises. Early intervention, including elective cholecystectomy, can help prevent complications like choledocholithiasis, biliary colic, and cholecystitis. Despite a lack of formal guidelines for routine cholecystectomy in asymptomatic patients, evidence supports early surgical management to prevent further complications and reduce the need for emergent procedures. This case series highlights the importance of early screening and elective cholecystectomy for SCD patients at risk of biliary disease. Early intervention can prevent acute complications, reduce hospitalizations, and improve the quality of life for patients with SCD. Future research and guidelines should focus on establishing protocols for screening and management of gallstone-related hepatobiliary complications in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.